Deserpidine (free base)

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 317650

CAS#: 131-01-1 (free base)

Description: Deserpidine (free base) is an antihypertensive drug related to reserpine which occurs naturally in Rauwolfia canescens. Deserpidine is a competitive inhibitor of the angiotensin converting enzyme (ACE). By competing with angiotensin I for ACE, deserpidine blocks the conversion of angiotensin I to angiotensin II, which is a potent vasoconstrictor. Reduced level of serum angiotensin II causes a decrease in blood pressure. Deserpidine also decreases angiotensin II-induced aldosterone secretion by the adrenal cortex.


Chemical Structure

img
Deserpidine (free base)
CAS# 131-01-1 (free base)

Theoretical Analysis

MedKoo Cat#: 317650
Name: Deserpidine (free base)
CAS#: 131-01-1 (free base)
Chemical Formula: C32H38N2O8
Exact Mass: 578.26
Molecular Weight: 578.650
Elemental Analysis: C, 66.42; H, 6.62; N, 4.84; O, 22.12

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Related CAS #: 6033-69-8 (HCl)   131-01-1 (free base)  

Synonym: Deserpidine (free base); Harmonyl; Raunormine; Recanescin; Canescine; Desepridine

IUPAC/Chemical Name: methyl (1R,15S,17R,18R,19S,20S)-18-methoxy-17-(3,4,5-trimethoxybenzoyloxy)-3,13-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-2(10),4,6,8-tetraene-19-carboxylate

InChi Key: CVBMAZKKCSYWQR-UHFFFAOYSA-N

InChi Code: InChI=1S/C32H38N2O8/c1-37-24-12-17(13-25(38-2)29(24)39-3)31(35)42-26-14-18-16-34-11-10-20-19-8-6-7-9-22(19)33-28(20)23(34)15-21(18)27(30(26)40-4)32(36)41-5/h6-9,12-13,18,21,23,26-27,30,33H,10-11,14-16H2,1-5H3

SMILES Code: COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=CC=CC=C45)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO, not in water

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 578.65 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Zhang H, Zhong D, Zhang Z, Dai X, Chen X. Liquid chromatography/tandem mass spectrometry method for the quantification of deserpidine in human plasma: Application to a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Oct 1;877(27):3221-5. doi: 10.1016/j.jchromb.2009.06.005. Epub 2009 Jun 10. PubMed PMID: 19620026.

2: Varchi G, Battaglia A, Samorì C, Baldelli E, Danieli B, Fontana G, Guerrini A, Bombardelli E. Synthesis of deserpidine from reserpine. J Nat Prod. 2005 Nov;68(11):1629-31. PubMed PMID: 16309312.

3: Fulton SC, Healy MD. Comparison of the effectiveness of deserpidine, reserpine, and alpha-methyltyrosine on brain biogenic amines. Fed Proc. 1976 Dec;35(14):2558-62. PubMed PMID: 11134.

4: Plotnikoff NP, Kastin AJ, Anderson MS, Schally AV. Deserpidine antagonism by a tripeptide, L-prolyl-L-leucyglycinamide. Neuroendocrinology. 1973;11(1):67-71. PubMed PMID: 4633626.

5: Everett GM, Borcherding J, Morse P. Effect of deserpidine and pargyline on the levels of biogenic amines in brain, liver and heart of mice. Res Commun Chem Pathol Pharmacol. 1972 Mar;3(2):245-8. PubMed PMID: 4679851.

6: da Rocha AL, Saldanha RV. [Clinical laboratory study of essential hypertension patients treated with a methylclothiazide deserpidine combination]. Hospital (Rio J). 1968 Oct;74(4):1299-304. Portuguese. PubMed PMID: 5304160.

7: Hutchison JC. Pargyline hydrochloride, methyclothiazide, and deserpidine in therapy of hypertension and prevention of "cheese reaction". Curr Ther Res Clin Exp. 1968 Mar;10(3):128-35. PubMed PMID: 4967000.

8: Shafei AZ, Abaza HH. Clinical and laboratory observations on the use of a combination of methyclothiazide and deserpidine in treatment of essential hypertension. J Egypt Med Assoc. 1968;51(1):48-56. PubMed PMID: 4876817.

9: Gaskell AJ, Joule JA. The acid catalysed C3 epimerization of reserpine and deserpidine. Tetrahedron. 1967 Oct;23(10):4053-63. PubMed PMID: 6065625.

10: de Faria CV. [Treatment of essential arterial hypertension by the methyclothiazide-deserpidine]. Rev Bras Med. 1967 May;24(5):331-3. Portuguese. PubMed PMID: 5603874.